The University of Texas MD Anderson Cancer Center  has received a $48.6 million, five-year grant from the National Cancer Institute (NCI) and an “exceptional” ranking, the highest possible, from the NCI’s extensive peer-review process.
Renewal of MD Anderson’s NCI Cancer Center Support Grant extends the institution’s status as a comprehensive cancer center, upheld since its designation as one of the first three such centers in 1971.
“MD Anderson’s people never rest on their past excellence, but instead continually push further to keep leading the field with our research-based care and doing all that we can for patients,” MD Anderson President Ronald DePinho, M.D., said.
“Our exceptional rating by 41 peer reviewers from across the country reflects the respect and admiration earned by the accomplishments of MD Anderson faculty, staff and trainees,” DePinho said. “We will continue to honor the trust and confidence placed in MD Anderson with our best efforts to improve cancer prevention and treatment as well as the quality of life of those who face these diseases.”
The grant, $9.7 million annually, supports 19 research programs and 16 shared resources that serve the entire institution. Research programs range from basic science to clinical trials of new therapies.